Phase II drugs under investigation for allergic conjunctivitis.

about

Clinical implications of mast cell involvement in allergic conjunctivitis.DS-70, a novel and potent α integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs

P2860

Q48361100-7A04C8A7-FC08-4106-8817-5F221EBCD870 Q56362461-0CC1206D-2957-4056-8203-92488F219337

P2860

Phase II drugs under investigation for allergic conjunctivitis.

Item

http://www.wikidata.org/entity/Q38234039

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Phase II drugs under investigation for allergic conjunctivitis.

@en

type

Item

label

Phase II drugs under investigation for allergic conjunctivitis.

@en

prefLabel

Phase II drugs under investigation for allergic conjunctivitis.

@en

P1476

Phase II drugs under investigation for allergic conjunctivitis.

@en

P2860

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).

Design of a superior cytokine antagonist for topical ophthalmic use

Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis

Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis

Twenty-first century mast cell stabilizers.

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis

Resolution, the grail for healthy ocular inflammation.

The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.

CpG motifs in bacterial DNA trigger direct B-cell activation.

P304

1671-1686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2014.944640

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Monica Baiula

Santi Spampinato

P577

2014-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25062902

http://www.w3.org/2001/XMLSchema#string

Phase II drugs under investigation for allergic conjunctivitis.

about

P2860

P2860

Phase II drugs under investigation for allergic conjunctivitis.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698